LAUREN VARGO: Open Payments
NPI 1689625808 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,896 in 196 payments from 20 companies in 2025. Trend: 2023 $2,764 · 2024 $3,740 · 2025 $5,896
Food & beverage: $4,576Consulting: $1,140Education: $180
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 21 | $1,925 |
| ABBVIE INC. | 32 | $997 |
| Janssen Biotech, Inc. | 25 | $585 |
| Incyte Corporation | 13 | $381 |
| GENZYME CORPORATION | 14 | $349 |
| Novartis Pharmaceuticals Corporation | 13 | $323 |
| Amgen Inc. | 12 | $198 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $185 |
| Galderma Laboratories, L.P. | 19 | $158 |
| PFIZER INC. | 8 | $151 |
Products named: Bimzelx, SKYRIZI, TREMFYA, DUPIXENT, RINVOQ, OPZELURA, COSENTYX, OTEZLA.
Industry payments across SC — which companies pay providers there.
